AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
CYPROTERONE
4 registrations across 3 African markets— 2 active
Markets with CYPROTERONE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| ANDROCUR Comprimé sécable / 50 MG | 🇹🇳Tunisia | JENAPHARM GmbH& Co.KG | expired | Aug 2020 |
| CYPROTERONE ACETATE STRAGEN Comprimé / 50 mg | 🇹🇳Tunisia | STRAGEN UK Limited | expired | Aug 2019 |
| MINERVA-35 | 🇿🇦South Africa | Bayer (Pty) Ltd û Isando | active | Jan 1900 |
| ANDROCUR COMPRIME | 🇲🇦Morocco | — | active | — |
CYPROTERONE in Africa — Regulatory Overview
CYPROTERONE is registered across 3 African markets with 4 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Morocco, South Africa. AfricaRegulatory refreshes this data daily from official government sources.
Of the 4 registrations, 2 (50%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.